Comparative evaluation of mesenchymal stem cells cultivation methods on biodegradable L-polylactide scaffold for the creation of tissue-engineered vascular implant
https://doi.org/10.24884/1682-6655-2018-17-1-61-68
Abstract
About the Authors
G. I. PopovRussian Federation
A. E. Kryukov
Russian Federation
Yu. A. Nashchekina
Russian Federation
E. M. Ivankova
Russian Federation
V. N. Vavilov
Russian Federation
V. E. Yudin
Russian Federation
P. V. Popryadukhin
Russian Federation
G. Yu. Yukina
Russian Federation
N. V. Smirnova
Russian Federation
References
1. Покровский А. В., Ивандаев А. С. Ежегодный отчет Российского общества ангиологов и сосудистых хирургов. Состояние сосудистой хирургии в России в 2016 году. - М., 2017. [Pokrovsky A.V, Ivandaev A.S. Annual report ofthe Russian Society of Angiologists and Vascular Surgeons. The state of vascular surgery in Russia in 2016. Moscow, 2017 (In Russ)].
2. Ahsan T, Nerem R. Bioengineered tissues: the science, the technology, and the industry. Orthod. Craniofac. 2005;8(3):134-140. doi: 10.1111/j.1601-6343.2005.00326.x.
3. Harskamp R, Lopes R, Baisden C, de Winter R, Alexander J. Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery. Ann. Surg. 2013;257(5):824-833. doi:10.1097/sla.0b013e318288c38d.
4. Hashi C, Zhu Y, Yang G et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc. Natl. Acad. Sci. 2007;104(29):11915-11920. doi: 10.1073/pnas.0704581104.
5. Kannan R, Salacinski H, Butler P, Hamilton G, Seifalian A. Current status of prosthetic bypass grafts: A review. J Biomed Mater Res B Appl Biomater. 2005;74B(1):570-581. doi: 10.1002/jbm.b.30247.
6. Kim F, Marhefka G, Ruggiero N, Adams S, Whellan D. Saphenous Vein Graft Disease. Cardiol Rev. 2013;21(2):101-109. doi: 10.1097/crd.0b013e3182736190.
7. Langer R, Vacanti J. Tissue engineering. Science. 1993;260(5110):920-926. doi: 10.1126/science.8493529.
8. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L, McAllister T. Technology Insight: the evolution of tissue-engineered vascular grafts - from research to clinical practice. Nat. Clin. Pract. Cardiovasc. Med. 2007;4(7):389-395. doi: 10.1038/ncpcardio0930.
9. Pawlowski K. Endothelial cell seeding of polymeric vascular grafts. Front Biosci. 2004;9(1-3):1412. doi: 10.2741/1302.
10. Pei M. Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J. 2002. doi: 10.1096/fj.02-0083fje.
11. Popryadukhin P, Popov G, Yukina G et al. Tissue-Engineered Vascular Graft of Small Diameter Based on Electrospun Polylactide Microfibers. Int J Biomater. 2017;2017:1-10. doi: 10.1155/2017/9034186.
12. World health statistics 2016: monitoring health for the SDGs, sustainable development goals. World Health Organization. Geneva, WHO Press, 2016:64-121.
13. Yow K, Ingram J, Korossis S, Ingham E, Homer-Vanniasinkam S. Tissue engineering of vascular conduits. Br. J. Surg 2006;93(6):652-661. doi:10.1002/bjs.5343.
14. Zhu M, Heydarkhan-Hagvall S, Hedrick M, Benhaim P, Zuk P. Manual Isolation of Adipose-derived Stem Cells from Human Lipoaspirates. J. Vis. Exp. 2013;79. doi:10.3791/50585.
Review
For citations:
Popov G.I., Kryukov A.E., Nashchekina Yu.A., Ivankova E.M., Vavilov V.N., Yudin V.E., Popryadukhin P.V., Yukina G.Yu., Smirnova N.V. Comparative evaluation of mesenchymal stem cells cultivation methods on biodegradable L-polylactide scaffold for the creation of tissue-engineered vascular implant. Regional blood circulation and microcirculation. 2018;17(1):61-68. (In Russ.) https://doi.org/10.24884/1682-6655-2018-17-1-61-68